Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- CheckyesterdayChange DetectedAdded a MedlinePlus Genetics topic for multiple myeloma and refreshed two major myeloma citations with newer revisions and corrections; one entry includes an Erratum, while the other shows the older revision.SummaryDifference0.5%
- Check8 days agoChange DetectedThe page has been updated to version 3.0.1, and the previous version 3.0.0 has been removed. Additionally, the topic of multiple myeloma related to MedlinePlus Genetics has been deleted.SummaryDifference0.2%
- Check15 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new medical terms related to treatments and diseases, while several previous terms and categories have been removed.SummaryDifference3%
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.